| Health / Medical Topics |
Canarypox-hIL-12 Melanoma Vaccine
A vaccine consisting of a replication-defective recombinant canarypox virus (ALVAC) that encodes the gene for human interleukin-12 (hIL-12). Produced mainly by B-cells, IL-12 is an endogenous cytokine that activates natural killer (NK) cells, promotes cytotoxic T lymphocyte (CTL) responses, induces the release of interferon-gamma (IFN-gamma), and may exhibit antitumor and anti-angiogenic effects. Vaccination with canarypox-hIL-12 melanoma vaccine may stimulate the host immune system to mount an immune response against tumor cells, thereby inhibiting tumor growth and/or metastasis. (NCI Thesaurus)
YOU MAY ALSO LIKE
A poxvirus of the genus Avipoxvirus. Has been adapted as a cloning vector (canarypox vector) for use as a mammalian expression…
Any of the genetically engineered live canarypox vectors with application in anti-cancer therapy. Canarypox vectors retain the pancytotropism of most poxviruses, but…
Any one of the antigens found on the surface of Canarypox virion particles.
The portion of the dental pulp cavity in the root of a tooth, extending from the pulp chamber to the apical…
Canalicular multispecific organic anion transporter 2 (1527 aa, ~169 kDa) is encoded by the human ABCC3 gene. This protein is involved in…
Canalicular multispecific organic anion transporter 1 (1545 aa, ~174 kDa) is encoded by the human ABCC2 gene. This protein is involved in…
